Aardvark Therapeutics AARD Income Statement (2024-2026)

NASDAQ AARD
$5.35 +0.08 (+1.52%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Aardvark Therapeutics Quarterly Income Statement

Periods 10 quarters
Latest Jun 2026

Aardvark Therapeutics reported net income of -$14.39M for the quarter ended Jun 2026. This income statement covers 10 quarters of results from Mar 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & Cost
Interest income
Interest Income - Total 0.10M0.59M1.00M0.72M1.18M1.49M1.35M1.12M0.89M0.69M
Operating Items
Research & DevelopmentR&D 1.21M4.03M4.07M8.06M7.75M13.14M13.74M14.30M16.57M10.46M
Wages, Salaries and OtherWages 0.45M1.07M1.20M1.54M2.06M2.70M3.05M4.19M3.71M3.38M
Selling, General & AdministrativeSG&A 0.86M2.03M1.03M1.39M2.71M2.70M3.97M4.41M5.90M4.63M
Other Operating ExpensesOther Opex 0.10M0.01M
Operating ExpensesOpex 2.17M6.07M5.09M9.45M10.47M15.85M17.70M18.70M22.46M15.08M
Operating IncomeOp. Inc -2.17M-6.07M-5.09M-9.45M-10.47M-15.85M-17.70M-18.70M-22.46M-15.08M
EBIT -2.17M-6.07M-5.09M-9.45M-10.47M-15.85M-17.70M-18.70M-22.46M-15.08M
Non-operating items
Non Operating Investment Income -0.11M0.03M-0.09M-0.05M-0.01M-0.01M0.04M-0.02M-0.01M0.00M
Interest & Investment IncomeInt & Inv Inc 0.10M0.59M1.00M0.72M1.18M1.49M1.35M1.12M0.89M0.69M
Non Operating IncomeNon Op. Inc. -0.01M0.62M0.91M0.67M1.16M1.48M1.39M1.11M0.88M0.70M
Net income details
EBT -2.07M-5.48M-4.09M-8.73M-9.29M-14.36M-16.35M-17.58M-21.57M-14.39M
Profit After TaxPAT -2.07M-5.48M-4.09M-8.73M-9.29M-14.36M-16.35M-17.58M-21.57M-14.39M
Income from Continuing OperationsIncome (Continuing) -2.07M-5.48M-4.09M-8.73M-9.29M-14.36M-16.35M-17.58M-21.57M-14.39M
Consolidated Net IncomeConsol Net Inc. -2.07M-5.48M-4.09M-8.73M-9.29M-14.36M-16.35M-17.58M-21.57M-14.39M
Income towards Parent CompanyParent Net Inc -2.18M-5.45M-4.18M-8.78M-9.31M-14.37M-16.32M-17.60M-21.59M-14.39M
Net Income towards Common StockholdersNet Income -2.18M-5.45M-4.18M-8.78M-9.31M-14.37M-16.32M-17.60M-21.59M-14.39M
Additional items
EPS (Basic) -0.55-1.37-1.05-2.20-0.71-0.66-0.75-0.90-0.99-0.66
EPS (Diluted) -0.55-1.37-1.05-2.20-0.71-0.66-0.75-0.90-0.99-0.66
Shares Outstanding 3.97M3.97M3.99M4.00M13.19M21.69M21.71M19.62M21.82M21.85M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 3.97M3.97M3.99M4.00M13.19M21.69M21.71M19.62M21.82M21.85M
Shares Outstanding (Entity)Shares Outstanding (Entity.) 3.97M3.97M4.06M4.07M13.19M21.69M21.75M21.82M21.82M21.88M
EBITDA -2.17M-6.08M-5.08M-9.44M-10.46M-15.84M-17.69M-18.69M-22.45M-15.07M

Aardvark Therapeutics Income Statement API

Pull Aardvark Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=AARD&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY